vs
ExlService Holdings, Inc.(EXLS)とニュースキン(NUS)の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい($542.6M vs $370.3M、ニュースキンの約1.5倍)。ExlService Holdings, Inc.の純利益率が高く(11.1% vs 3.9%、差は7.2%)。ExlService Holdings, Inc.の前年同期比売上増加率が高い(12.7% vs -16.9%)。ExlService Holdings, Inc.の直近四半期フリーキャッシュフローが多い($106.5M vs $5.9M)。過去8四半期でExlService Holdings, Inc.の売上複合成長率が高い(11.5% vs -5.8%)
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
ニュースキン・エンタープライズはアメリカのマルチレベルマーケティング企業で、スキンケア製品や栄養補助食品の開発・販売を手がけています。Nu SkinとPharmanexの2つのブランドを擁し、現在54の市場で事業を展開し、約120万人の独立販売店のネットワークを通じて製品を販売しています。
EXLS vs NUS — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $542.6M | $370.3M |
| 純利益 | $60.2M | $14.5M |
| 粗利率 | 38.6% | 70.7% |
| 営業利益率 | 14.4% | 6.3% |
| 純利益率 | 11.1% | 3.9% |
| 売上前年比 | 12.7% | -16.9% |
| 純利益前年比 | 18.9% | 140.1% |
| EPS(希薄化後) | $0.38 | $0.27 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $370.3M | ||
| Q3 25 | $529.6M | $364.2M | ||
| Q2 25 | $514.5M | $386.1M | ||
| Q1 25 | $501.0M | $364.5M | ||
| Q4 24 | $481.4M | $445.6M | ||
| Q3 24 | $472.1M | $430.1M | ||
| Q2 24 | $448.4M | $439.1M | ||
| Q1 24 | $436.5M | $417.3M |
| Q4 25 | $60.2M | $14.5M | ||
| Q3 25 | $58.2M | $17.1M | ||
| Q2 25 | $66.1M | $21.1M | ||
| Q1 25 | $66.6M | $107.5M | ||
| Q4 24 | $50.7M | $-36.1M | ||
| Q3 24 | $53.0M | $8.3M | ||
| Q2 24 | $45.8M | $-118.3M | ||
| Q1 24 | $48.8M | $-533.0K |
| Q4 25 | 38.6% | 70.7% | ||
| Q3 25 | 38.5% | 70.5% | ||
| Q2 25 | 37.7% | 68.8% | ||
| Q1 25 | 38.6% | 67.8% | ||
| Q4 24 | 38.1% | 62.7% | ||
| Q3 24 | 37.8% | 70.1% | ||
| Q2 24 | 37.1% | 70.0% | ||
| Q1 24 | 37.4% | 70.5% |
| Q4 25 | 14.4% | 6.3% | ||
| Q3 25 | 14.4% | 5.9% | ||
| Q2 25 | 15.8% | 8.0% | ||
| Q1 25 | 15.7% | -2.7% | ||
| Q4 24 | 14.8% | -11.9% | ||
| Q3 24 | 14.7% | 4.2% | ||
| Q2 24 | 13.7% | -28.6% | ||
| Q1 24 | 14.1% | 2.1% |
| Q4 25 | 11.1% | 3.9% | ||
| Q3 25 | 11.0% | 4.7% | ||
| Q2 25 | 12.8% | 5.5% | ||
| Q1 25 | 13.3% | 29.5% | ||
| Q4 24 | 10.5% | -8.1% | ||
| Q3 24 | 11.2% | 1.9% | ||
| Q2 24 | 10.2% | -26.9% | ||
| Q1 24 | 11.2% | -0.1% |
| Q4 25 | $0.38 | $0.27 | ||
| Q3 25 | $0.36 | $0.34 | ||
| Q2 25 | $0.40 | $0.43 | ||
| Q1 25 | $0.40 | $2.14 | ||
| Q4 24 | $0.31 | $-0.73 | ||
| Q3 24 | $0.33 | $0.17 | ||
| Q2 24 | $0.28 | $-2.38 | ||
| Q1 24 | $0.29 | $-0.01 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | $239.8M |
| 総負債低いほど良い | $298.6M | — |
| 株主資本純資産 | $912.7M | $805.2M |
| 総資産 | $1.7B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | $239.8M | ||
| Q3 25 | $390.1M | $253.0M | ||
| Q2 25 | $353.3M | $265.4M | ||
| Q1 25 | $331.4M | $213.6M | ||
| Q4 24 | $340.6M | $198.0M | ||
| Q3 24 | $325.8M | $237.8M | ||
| Q2 24 | $276.1M | $232.9M | ||
| Q1 24 | $246.2M | $221.2M |
| Q4 25 | $298.6M | — | ||
| Q3 25 | $354.8M | — | ||
| Q2 25 | $260.0M | — | ||
| Q1 25 | $307.3M | — | ||
| Q4 24 | $288.5M | — | ||
| Q3 24 | $344.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $912.7M | $805.2M | ||
| Q3 25 | $952.4M | $799.8M | ||
| Q2 25 | $1.1B | $787.8M | ||
| Q1 25 | $1.0B | $754.0M | ||
| Q4 24 | $929.9M | $651.5M | ||
| Q3 24 | $907.6M | $706.9M | ||
| Q2 24 | $852.6M | $686.2M | ||
| Q1 24 | $803.3M | $810.2M |
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.7B | $1.4B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.4B | $1.7B |
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $16.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | $5.9M |
| FCFマージンFCF / 売上 | 19.6% | 1.6% |
| 設備投資強度設備投資 / 売上 | 2.0% | 2.9% |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 1.15× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | $46.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $16.6M | ||
| Q3 25 | $120.7M | $27.5M | ||
| Q2 25 | $109.4M | $35.8M | ||
| Q1 25 | $3.2M | $389.0K | ||
| Q4 24 | $105.3M | $25.8M | ||
| Q3 24 | $110.1M | $31.4M | ||
| Q2 24 | $74.9M | $51.2M | ||
| Q1 24 | $-21.9M | $3.3M |
| Q4 25 | $106.5M | $5.9M | ||
| Q3 25 | $106.4M | $17.6M | ||
| Q2 25 | $95.0M | $35.8M | ||
| Q1 25 | $-9.7M | $-13.2M | ||
| Q4 24 | $95.3M | $13.2M | ||
| Q3 24 | $97.3M | $22.8M | ||
| Q2 24 | $62.8M | $43.1M | ||
| Q1 24 | $-33.1M | $-9.0M |
| Q4 25 | 19.6% | 1.6% | ||
| Q3 25 | 20.1% | 4.8% | ||
| Q2 25 | 18.5% | 9.3% | ||
| Q1 25 | -1.9% | -3.6% | ||
| Q4 24 | 19.8% | 3.0% | ||
| Q3 24 | 20.6% | 5.3% | ||
| Q2 24 | 14.0% | 9.8% | ||
| Q1 24 | -7.6% | -2.1% |
| Q4 25 | 2.0% | 2.9% | ||
| Q3 25 | 2.7% | 2.7% | ||
| Q2 25 | 2.8% | 0.0% | ||
| Q1 25 | 2.6% | 3.7% | ||
| Q4 24 | 2.1% | 2.8% | ||
| Q3 24 | 2.7% | 2.0% | ||
| Q2 24 | 2.7% | 1.9% | ||
| Q1 24 | 2.6% | 2.9% |
| Q4 25 | 1.95× | 1.15× | ||
| Q3 25 | 2.08× | 1.61× | ||
| Q2 25 | 1.66× | 1.69× | ||
| Q1 25 | 0.05× | 0.00× | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.08× | 3.79× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
NUS
| Other | $161.9M | 44% |
| Mainland China Segment | $52.0M | 14% |
| Southeast Asia Pacific Segment | $50.5M | 14% |
| Europe And Africa Segment | $41.8M | 11% |
| Hong Kong Taiwan Segment | $29.6M | 8% |
| South Korea Segment | $28.4M | 8% |
| Rhyz Other Segment | $6.1M | 2% |